Medical Ventures to sell Metricath Gemini catheter in Europe

By Elaine Rigoli

Tampa, Fla., July 10 - Medical Ventures Corp. has received European CE Mark approval for its Metricath Gemini balloon-catheter product, a device used during angioplasty procedures to measure and treat damaged blood vessels in patients suffering from cardiovascular disease.

The approval allows the company to market and sell the product in the European Union, where more than 800,000 people undergo angioplasties each year, according to a news release.

The TUV Rhineland of Cologne, Germany, granted CE Mark approval for the Metricath Gemini device for use in both coronary and peripheral (non-coronary) vascular applications throughout the European Union.

With approval in place, Medical Ventures said it will begin marketing the product through its existing distributors in Italy, Greece, Austria and Switzerland.

The company said it is pursuing additional distribution agreements in other European countries.

Medical Ventures is a medical-device company located in Richmond, B.C.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.